Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05657145 · ClinicalTrials.gov registry record
Visualization of the Papilla Through Use of the NuView Device in Patients With FAP
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT05657145 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT05657145 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The goal of this observational study is to test the NuView device in participants with familial adenomatous polyposis (FAP). The main question it aims to answer is: * can the papilla be visualized using a forward-facing endoscope outfitted with the NuView device. Participants will undergo standard of care esophagogastroduodenoscopy with an additional endoscopic exam using NuView device, for which participant have given prior consent.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-01-27 |
| Est. Completion | 2025-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05657145
The ClinicalTrials.gov registry entry for NCT05657145 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05657145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05657145 about?
NCT05657145 is a clinical study titled "Visualization of the Papilla Through Use of the NuView Device in Patients With FAP". The goal of this observational study is to test the NuView device in participants with familial adenomatous polyposis (FAP). The main question it aims to answer is: * can the papilla be visualized using a forward-facing endoscope outfitted with the NuView device. Participants will undergo standard ...
What is the current status of trial NCT05657145?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2023-01-27. Estimated completion is 2025-12-30.
Who is sponsoring clinical trial NCT05657145?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.